- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
5
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
5 companies
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩36,600.00
7D
-2.1%
1Y
8.6%
ALTEOGEN
Market Cap: ₩20.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩298,000.00
7D
-9.0%
1Y
-9.3%
HansBiomed
Market Cap: ₩293.1b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩20,550.00
7D
-15.1%
1Y
163.1%
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩393,000.00
7D
-5.8%
1Y
-41.8%
DreamCIS
Market Cap: ₩83.4b
Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.
A223250
₩3,390.00
7D
-5.2%
1Y
-1.5%